Nexera MX Accelerates workflow and improves analytical efficiency
Shimadzu’s Nexera MX ultra-fast multianalyte LC-MS system offers up to double the sample processing capability of the conventional approach. The Nexera MX features two analytical flow lines in a single LC-MS system. This setup maximizes operating efficiency by alternating between the two lines for injecting of samples. Capable of rapidly processing large numbers of samples, the Nexera MX will help to improve the workflow of customers. The Nexera MX system also includes the LabSolutions Insight software, providing assistance with quantitative analysis of large volumes of data.
Contact details:
Shimadzu Europa GmbH
Albert-Hahn-Strasse 6-10
47269 Duisburg, Germany
phone: +49 (0) 203-7687-0
shimadzu@shimadzu.euwww.shimadzu.eu
Drug Shortages and Complying with FDA’s 21 CFR 211.110 Guidance
April 2nd 2025Susan J. Schniepp, distinguished fellow at Regulatory Compliance Associates, and Rona LeBlanc-Rivera, PhD, principal consultant, Regulatory Affairs at Regulatory Compliance Associates, answer some questions about FDA’s January 2025 21 CFR 211.110 guidance document.
Transformations in Drug Development for Cell and Gene Therapies
March 28th 2025As a recognized leader in immunophenotyping for clinical trials, Kevin Lang from PPD discusses how spectral flow cytometry is transforming drug development, particularly in cell and gene therapies like CAR-T. He also dives into his award-winning research, including his 2024 WRIB Poster Award-winning work, and his insights from presenting at AAPS PharmSci360.
Advancing Clinical Trials with Spectral Flow Cytometry: A Conversation with Kevin Lang
March 28th 2025As a recognized leader in immunophenotyping for clinical trials, Kevin Lang from PPD discusses how spectral flow cytometry is transforming drug development, particularly in cell and gene therapies like CAR-T. He also dives into his award-winning research, including his 2024 WRIB Poster Award-winning work, and his insights from presenting at AAPS PharmSci360.
